120 related articles for article (PubMed ID: 36316614)
1. A Real-World Matched Cohort Study of the Effect of Concomitant Amiodarone or Diltiazem Administration on Apixaban Peak and Trough Concentrations.
Bookstaver DA; Ainsworth M; Gleaton M; Milner E
Am J Cardiovasc Drugs; 2023 Jan; 23(1):59-66. PubMed ID: 36316614
[TBL] [Abstract][Full Text] [Related]
2. Assessment of Anti-Xa activity in patients receiving concomitant apixaban with strong p-glycoprotein inhibitors and statins.
Milner E; Ainsworth M; Gleaton M; Bookstaver D
J Clin Pharm Ther; 2022 May; 47(5):668-675. PubMed ID: 35032137
[TBL] [Abstract][Full Text] [Related]
3. Amiodarone, Verapamil, or Diltiazem Use With Direct Oral Anticoagulants and the Risk of Hemorrhage in Older Adults.
Hill K; Sucha E; Rhodes E; Bota S; Hundemer GL; Clark EG; Canney M; Harel Z; Wang TF; Carrier M; Wijeysundera HC; Knoll G; Sood MM
CJC Open; 2022 Mar; 4(3):315-323. PubMed ID: 35386137
[TBL] [Abstract][Full Text] [Related]
4. Apixaban concentration variability and relation to clinical outcomes in real-life patients with atrial fibrillation.
Mavri A; Vene N; Božič-Mijovski M; Miklič M; Söderblom L; Pohanka A; Malmström RE; Antovic J
Sci Rep; 2021 Jul; 11(1):13908. PubMed ID: 34230559
[TBL] [Abstract][Full Text] [Related]
5. Effect of ketoconazole and diltiazem on the pharmacokinetics of apixaban, an oral direct factor Xa inhibitor.
Frost CE; Byon W; Song Y; Wang J; Schuster AE; Boyd RA; Zhang D; Yu Z; Dias C; Shenker A; LaCreta F
Br J Clin Pharmacol; 2015 May; 79(5):838-46. PubMed ID: 25377242
[TBL] [Abstract][Full Text] [Related]
6. Comparison of Anti-Xa Activity in Patients Receiving Apixaban or Rivaroxaban.
Bookstaver DA; Sparks K; Pybus BS; Davis DK; Marcsisin SR; Sousa JC
Ann Pharmacother; 2018 Mar; 52(3):251-256. PubMed ID: 29047306
[TBL] [Abstract][Full Text] [Related]
7. Apixaban plasma concentrations in patients with obesity.
Al-Aieshy F; Skeppholm M; Fyrestam J; Johansson F; Pohanka A; Malmström RE
Eur J Clin Pharmacol; 2024 Jun; ():. PubMed ID: 38822847
[TBL] [Abstract][Full Text] [Related]
8. Effect of Enzyme-Inducing Antiseizure Medications on the Risk of Sub-Therapeutic Concentrations of Direct Oral Anticoagulants: A Retrospective Cohort Study.
Perlman A; Goldstein R; Choshen Cohen L; Hirsh-Raccah B; Hakimian D; Matok I; Kalish Y; Singer DE; Muszkat M
CNS Drugs; 2021 Mar; 35(3):305-316. PubMed ID: 33595834
[TBL] [Abstract][Full Text] [Related]
9. Unexpected excessive apixaban exposure: case report of a patient with polymorphisms of multiple apixaban elimination pathways.
Huppertz A; Grond-Ginsbach C; Dumschat C; Foerster KI; Burhenne J; Weiss J; Czock D; Purrucker JC; Rizos T; Haefeli WE
BMC Pharmacol Toxicol; 2019 Aug; 20(1):53. PubMed ID: 31464657
[TBL] [Abstract][Full Text] [Related]
10. The influence of diltiazem hydrochloride on trough serum digoxin concentrations.
North DS; Mattern AL; Hiser WW
Drug Intell Clin Pharm; 1986 Jun; 20(6):500-3. PubMed ID: 3720546
[TBL] [Abstract][Full Text] [Related]
11. Interindividual Variability of Apixaban Plasma Concentrations: Influence of Clinical and Genetic Factors in a Real-Life Cohort of Atrial Fibrillation Patients.
Roşian AN; Roşian ŞH; Kiss B; Ştefan MG; Trifa AP; Ober CD; Anchidin O; Buzoianu AD
Genes (Basel); 2020 Apr; 11(4):. PubMed ID: 32316515
[TBL] [Abstract][Full Text] [Related]
12. Apixaban Levels in Octogenarian Patients with Non-valvular Atrial Fibrillation.
Nissan R; Spectre G; Hershkovitz A; Green H; Shimony S; Cooper L; Nakav S; Shochat T; Grossman A; Fuchs S
Drugs Aging; 2019 Feb; 36(2):165-177. PubMed ID: 30460518
[TBL] [Abstract][Full Text] [Related]
13. The real world use of combined P-glycoprotein and moderate CYP3A4 inhibitors with rivaroxaban or apixaban increases bleeding.
Hanigan S; Das J; Pogue K; Barnes GD; Dorsch MP
J Thromb Thrombolysis; 2020 May; 49(4):636-643. PubMed ID: 31925665
[TBL] [Abstract][Full Text] [Related]
14. Diltiazem increases tacrolimus concentrations.
Hebert MF; Lam AY
Ann Pharmacother; 1999 Jun; 33(6):680-2. PubMed ID: 10410178
[TBL] [Abstract][Full Text] [Related]
15. Intravenous diltiazem is superior to intravenous amiodarone or digoxin for achieving ventricular rate control in patients with acute uncomplicated atrial fibrillation.
Siu CW; Lau CP; Lee WL; Lam KF; Tse HF
Crit Care Med; 2009 Jul; 37(7):2174-9; quiz 2180. PubMed ID: 19487941
[TBL] [Abstract][Full Text] [Related]
16. Conversion from Twice-Daily Prograf
Yau WP; Loh CW; Vathsala A
Eur J Drug Metab Pharmacokinet; 2019 Aug; 44(4):481-492. PubMed ID: 30471066
[TBL] [Abstract][Full Text] [Related]
17. Effects of ranolazine with atenolol, amlodipine, or diltiazem on exercise tolerance and angina frequency in patients with severe chronic angina: a randomized controlled trial.
Chaitman BR; Pepine CJ; Parker JO; Skopal J; Chumakova G; Kuch J; Wang W; Skettino SL; Wolff AA;
JAMA; 2004 Jan; 291(3):309-16. PubMed ID: 14734593
[TBL] [Abstract][Full Text] [Related]
18. Drug interactions and pharmacogenetic factors contribute to variation in apixaban concentration in atrial fibrillation patients in routine care.
Gulilat M; Keller D; Linton B; Pananos AD; Lizotte D; Dresser GK; Alfonsi J; Tirona RG; Kim RB; Schwarz UI
J Thromb Thrombolysis; 2020 Feb; 49(2):294-303. PubMed ID: 31564018
[TBL] [Abstract][Full Text] [Related]
19. Effect of genetic polymorphisms of CYP3A5 and MDR1 on cyclosporine concentration during the early stage after renal transplantation in Chinese patients co-treated with diltiazem.
Wang Y; Wang C; Li J; Wang X; Zhu G; Chen X; Bi H; Huang M
Eur J Clin Pharmacol; 2009 Mar; 65(3):239-47. PubMed ID: 18936931
[TBL] [Abstract][Full Text] [Related]
20. Comparison of Anti-factor Xa Activity Among Three Different Factor Xa Inhibitors in Non-valvular Atrial Fibrillation Patients with Renal Impairment.
Tobe A; Osanai H; Tanaka A; Sakaguchi T; Kambara T; Nakashima Y; Asano H; Ishii H; Ajioka M; Murohara T
Clin Drug Investig; 2020 Jun; 40(6):567-573. PubMed ID: 32314297
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
